Skip to content

Multiple Myeloma in Combination with Isatuximab and Dexamethasone in Adult Patients Who Have Received At Least Two Prior Therapies Including Lenalidomide and A Proteasome Inhibitor

A selection of medicines used for Multiple Myeloma in Combination with Isatuximab and Dexamethasone in Adult Patients Who Have Received At Least Two Prior Therapies Including Lenalidomide and A Proteasome Inhibitor is listed below, including Pomalidomide. Products containing Pomalidomide feature in this group. Prices and product details are shown for comparison.

Pomalyst

Pomalidomide

4mg

Treats relapsed and refractory multiple myeloma by modulating the immune system and directly targeting tumour cells through cereblon binding, producing anti-proliferative, anti-angiogenic and immunomodulatory effects.

From$63.90/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.